You are here:Home-Chemical Inhibitors & Agonists-JAK/STAT Signaling-JAK-Cerdulatinib
Cerdulatinib

Chemical Structure : Cerdulatinib

CAS No.: 1198300-79-6

Cerdulatinib (PRT062070, PRT2070)

Catalog No.: PC-73204Not For Human Use, Lab Use Only.

Cerdulatinib (PRT062070) is a potent, ATP-competitive, orally active dual SYK/JAK inhibitor with IC50 of 32 nM (Syk), 0.5-12 nM (JAK1/2/3, Tyk2).

Packing Price Stock Quantity
25 mg $158 In stock
50 mg $268 In stock
100 mg $438 In stock
200 mg $718 In stock
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Cerdulatinib (PRT062070) is a potent, ATP-competitive, orally active dual SYK/JAK inhibitor with IC50 of 32 nM (Syk), 0.5-12 nM (JAK1/2/3, Tyk2).
Cerdulatinib (PRT062070) has broad anti-tumor activity in both ABC and GCB types of diffuse large B cell lymphoma; Cerdulatinib (PRT062070) demonstrates specificity towards JAK1/JAK3 and TYK2, but not JAK2-mediated responses at cellular level, does not inhibit TCR signaling or PKC signaling in whole blood.
Cerdulatinib (PRT062070) blocks cell cycle in both ABC and GCB subtypes of DLBCL via inhibition of RB phosphorylation and down-regulation of cyclin E.
Cerdulatinib (PRT062070) induces cell cycle arrest and apoptosis under the condition of BCR stimulation in DLBCL cell lines.
Cerdulatinib (PRT062070) suppressed inflammation and autoantibody generation in a rat collagen-induced arthritis model and blocked B-cell activation and splenomegaly in a mouse model of chronic B-cell antigen receptor stimulation.

Physicochemical Properties

M.Wt 445.54
Formula C20H27N7O3S
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

References

1. Coffey G, et al. J Pharmacol Exp Ther. 2014 Dec;351(3):538-48.

2. Ma J, et al. Oncotarget. 2015 Dec 22;6(41):43881-96.

3. Blunt MD, et al. Clin Cancer Res. 2017 May 1;23(9):2313-2324.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: